The gore® cardioform septal occluder instructions for use states: adverse events associated with the use of the occluder may include but are not limited to: new arrhythmia requiring treatment.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
The following was reported from a study: on (b)(6) 2023, a patient underwent treatment to close a long tunnel patent foramen ovale with atrial septal aneurysm using gore® cardioform septal occluder (gso).On (b)(6) 2023, the patient lost consciousness while defecating in a bathroom upon waking up.The patient was admitted to the hospital and a second degree atrioventricular block was observed.On (b)(6) 2023, a pacemaker was implanted.On (b)(6) 2023, the patient recovered.Reportedly, the physician thought that the second degree atrioventricular block was not related to the gso device and/or the procedure to implant the gso device.The association of the advanced atrioventricular block with the closure device was unlikely.
|